ERBB2 and neoplasm: Significant variables associated with recurrence were less than 39 years (P = 0.003), chemotherapy as the initial treatment after surgery (P = 0.028), tumour size greater than 2 cm (P = 0.006), positive involvement of surgical margins (P = 0.001), and Her-2 expression (P = 0.016).